import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "where-to-buy-kisspeptin-research-guide",
  title: "Where to Buy Kisspeptin: A Researcher's Sourcing Guide",
  description:
    "What researchers need to know before purchasing Kisspeptin-10 or Kisspeptin-54 — isoform sourcing considerations, synthesis standards, COA requirements, receptor binding verification, and why compound identity is especially important for neuroendocrine research.",
  category: "Quality & Testing",
  readMinutes: 9,
  publishedAt: "2026-06-06",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Kisspeptin is a family of neuropeptides encoded by the KISS1 gene, acting as potent agonists of the GPR54 receptor (also termed KISS1R). In the reproductive neuroendocrinology literature, kisspeptin neurons in the hypothalamic arcuate and anteroventral periventricular nuclei represent the central gate of the hypothalamic-pituitary-gonadal (HPG) axis — regulating GnRH pulse generation and the downstream LH and FSH surges required for ovulation, spermatogenesis, and pubertal onset.",
    },
    {
      type: "paragraph",
      text: "The research market supplies two primary isoforms: Kisspeptin-10 (KP-10, the C-terminal decapeptide YNWNSFGLRF-NH₂) and Kisspeptin-54 (KP-54, the full 54-amino acid mature peptide). Sourcing decisions must begin with isoform selection — these are different compounds with different molecular weights, synthesis complexity, and research applications, though both activate GPR54.",
    },
    {
      type: "heading",
      text: "Isoform Selection: KP-10 vs. KP-54",
    },
    {
      type: "paragraph",
      text: "Kisspeptin-10 (MW ~1302 Da) is the minimal active fragment — it contains the C-terminal decapeptide sequence sufficient for full GPR54 activation. KP-10 has been used in the majority of human clinical studies (including GnRH stimulation studies), is structurally simpler to synthesize at high purity, and is the standard isoform for acute in vivo bolus experiments in rodent models.",
    },
    {
      type: "paragraph",
      text: "Kisspeptin-54 is the full-length processed KISS1 peptide (MW ~6536 Da) that circulates endogenously in humans. KP-54 has a longer plasma half-life than KP-10 and has been used specifically in studies examining pulsatile GnRH release, placental kisspeptin physiology, and infertility models where the extended half-life is an experimental design advantage. Some researchers also argue that KP-54 more accurately recapitulates endogenous kisspeptin signaling than the truncated fragment.",
    },
    {
      type: "paragraph",
      text: "When specifying a kisspeptin purchase, confirm the isoform explicitly — KP-10, KP-54, or Kisspeptin-13 (another isoform occasionally used in specific neuroendocrine models). The COA must identify the specific isoform by name and molecular weight. A generic 'Kisspeptin' COA without isoform specification is insufficient for research use.",
    },
    {
      type: "heading",
      text: "Synthesis Requirements by Isoform",
    },
    {
      type: "subheading",
      text: "Kisspeptin-10",
    },
    {
      type: "paragraph",
      text: "KP-10 is a 10-residue C-terminally amidated peptide (YNWNSFGLRF-NH₂). The synthesis is relatively tractable at this length and should achieve ≥98% HPLC purity in research-grade production. The tryptophan residues (W at positions 3 and 5) are susceptible to oxidation — during synthesis, purification, and storage. Oxidized tryptophan produces a mass shift of +16 Da per residue that is detectable by MS, and oxidized KP-10 has reduced GPR54 binding affinity. COA mass spectrometry should confirm absence of oxidation adducts.",
    },
    {
      type: "paragraph",
      text: "Like GHRP-6, KP-10 is C-terminally amidated — required for full GPR54 activation. The mass spectrometry data should confirm the amide form (nominal MW 1302.5 Da) versus the free acid (MW 1303.5 Da). Some commodity suppliers deliver free-acid product mislabeled as the amide form.",
    },
    {
      type: "subheading",
      text: "Kisspeptin-54",
    },
    {
      type: "paragraph",
      text: "KP-54 is a 54-amino acid peptide with MW ~6536 Da — comparable in synthesis complexity to TB-500. The longer sequence amplifies all of the synthesis challenges: higher deletion sequence probability, greater impurity diversity, and more demanding HPLC purification requirements for an amphipathic larger peptide. Research-grade KP-54 should achieve ≥95% HPLC purity with mass spectrometry confirmation of the full 54-AA sequence.",
    },
    {
      type: "heading",
      text: "GPR54 Receptor Context: Why Identity Verification Is Non-Negotiable",
    },
    {
      type: "paragraph",
      text: "GPR54 is expressed at multiple central and peripheral sites: hypothalamic KNDy neurons (co-expressing kisspeptin, neurokinin B, and dynorphin), pituitary gonadotrophs, gonads, and placental trophoblasts. The downstream effects of kisspeptin signaling — GnRH pulse generation, LH surge, FSH modulation — are tightly dose- and timing-dependent in research models.",
    },
    {
      type: "paragraph",
      text: "A deletion sequence impurity in a kisspeptin preparation may have partial GPR54 agonist activity, inverse agonist activity, or antagonist-like effects depending on the specific truncation. For studies examining GnRH pulse frequency or LH amplitude — which are the primary read-outs of the HPG axis — impurity-mediated receptor modulation would produce systematically biased results that cannot be attributed to kisspeptin itself. This is why COA identity verification is not a bureaucratic formality for kisspeptin research — it is scientifically necessary.",
    },
    {
      type: "heading",
      text: "Complete COA Requirements for Research-Grade Kisspeptin",
    },
    {
      type: "list",
      items: [
        "Isoform specification: KP-10, KP-54, or KP-13 explicitly named; molecular weight confirming isoform identity",
        "HPLC purity: ≥98% for KP-10; ≥95% for KP-54; full chromatogram with peak table",
        "Mass spectrometry: ESI-MS confirming MW within 0.1% of theoretical; for KP-10 specifically, confirm C-terminal amide form and absence of Trp oxidation (+16 Da adducts)",
        "Sequence confirmation: MS/MS fragmentation or amino acid analysis confirming full sequence identity",
        "Water content: Karl Fischer titration for accurate peptide mass calculation",
        "Endotoxin (LAL): required for any in vivo research application — mandatory for hypothalamic injection or systemic administration models",
        "Lot/batch number matching shipped vials",
        "For KP-10: explicit C-terminal amide confirmation; for KP-54: N- and C-terminus specification",
      ],
    },
    {
      type: "heading",
      text: "Storage and Stability",
    },
    {
      type: "paragraph",
      text: "Lyophilized Kisspeptin-10 is stable at -20°C for 12–24 months. The tryptophan residues are the primary oxidation risk: protect from light during storage and minimize exposure to dissolved oxygen during reconstitution. Reconstitute in degassed water or 1% acetic acid solution for improved stability. Reconstituted KP-10 at 0.5 mg/mL should be used within 2–4 weeks when stored at 4°C.",
    },
    {
      type: "paragraph",
      text: "Kisspeptin-54 is less stable than KP-10 in solution due to its larger size and greater susceptibility to proteolytic degradation. Lyophilized storage at -20°C is recommended with minimal freeze-thaw cycles. Reconstituted KP-54 should be prepared in small aliquots and used within 1–2 weeks.",
    },
    {
      type: "heading",
      text: "Red Flags When Sourcing Kisspeptin",
    },
    {
      type: "list",
      items: [
        "No isoform specification on COA — 'Kisspeptin' alone is not a sufficient identity description",
        "No C-terminal amide confirmation for KP-10 — this is a critical structural feature, not an optional detail",
        "Mass spectrometry showing +16 Da or +32 Da adducts — indicates tryptophan oxidation during synthesis or storage",
        "HPLC purity below 98% for KP-10 — a 10-residue peptide at sub-98% purity indicates poor synthesis quality",
        "No endotoxin data for a peptide intended for CNS or neuroendocrine in vivo applications",
        "Generic COA without lot-specific traceability",
        "Significant price undercutting without quality explanation — low-cost production typically reflects 90–94% purity commodity synthesis",
      ],
    },
    {
      type: "heading",
      text: "Verifying Your Kisspeptin Source",
    },
    {
      type: "paragraph",
      text: "Before purchasing kisspeptin, request the lot-specific COA with explicit isoform identification, HPLC chromatogram, ESI-MS confirming the amide form and absence of oxidation adducts, Karl Fischer water content, and LAL endotoxin result. For KP-54, additionally request sequence confirmation by MS/MS or amino acid analysis.",
    },
    {
      type: "paragraph",
      text: "The GPR54 axis governs fundamental reproductive and metabolic physiology. Kisspeptin research that produces false results due to compound quality failures misinforms downstream research programs. The cost of verified documentation is trivial relative to the cost of a failed experiment or a retracted finding.",
    },
    {
      type: "callout",
      text: "Nexphoria's Kisspeptin-10 and Kisspeptin-54 are supplied with lot-specific COA documentation including isoform-confirmed HPLC chromatogram, ESI-MS with C-terminal amide and oxidation status verification, Karl Fischer water content, and LAL endotoxin data — from independent third-party laboratories. Request your COA before placing an order.",
    },
    {
      type: "disclaimer",
      text: "Kisspeptin and all compounds on the Nexphoria platform are sold exclusively for licensed laboratory research use. Not for human consumption. Compliance with all applicable local, state, and federal regulations is the sole responsibility of the purchasing researcher.",
    },
  ],
};
